“…Since native renal biopsy was first described in 1951, technical and procedural advances have been made with improvements in ultrasound (US) imaging, the application of real-time sonographic guidance, the use of automated spring-loaded biopsy devices, and cortex-targeting biopsy techniques (1,2). Despite these technical and procedural improvements, native renal biopsy confers a potentially serious risk of bleeding that can lead to pain, loss of the kidney, and death, and can require hospitalization, analgesia, blood transfusion, and image-guided or surgical intervention (2).…”